Mei Lin Zhang

Department of Oncology, Fudan University, Shanghai, China, China

Publications

• Perspective Article   
  CRISPR-Cas9 in Cancer Therapy: A New Frontier
  Author(s): Mei Lin Zhang*
  
  DOI: 10.4172/0976-1233.005

  HTML PDF